Related Experiment Video
Updated: Aug 10, 2026

Isolation of Valvular Endothelial Cells
Published on: December 29, 2010
Serratia endocarditis. A follow-up report
Abstract:
Seventeen new cases of Serratia marcescens endocarditis observed in the San Francisco Bay Area since June 1974 are presented. Fifteen patients had a history of illicit intravenous drug use and four patients had prosthetic heart valves. Seven patients with infection of right-sided heart valves did well, although surgery was required in two for persistent fever or recurrent pulmonary emboli. Only three of ten patients with left-sided infection survived despite synergistic antibiotic combinations and high serum bactericidal titers. Fifteen isolates of Serratia from patients with endocarditis were serotyped, and none of these serotypes corresponded to the pigmented strain aerosolized by the US Army in the Bay Area in 1951. The isolation of the same Serratia strain from two patients and their shared injection paraphernalia provided insight into the pathogenesis of endocarditis in the intravenous drug user. A revised therapeutic approach to this difficult infection is presented.
Insights
Serratia marcescens endocarditis is a serious infection, particularly in intravenous drug users. Early diagnosis and a revised treatment approach are crucial for improving survival rates in these challenging cases.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Serratia marcescens endocarditis is a rare but severe infection.
- Intravenous drug use is a significant risk factor.
- Prosthetic heart valves are also associated with increased risk.
Purpose of the Study:
- To present new cases of Serratia marcescens endocarditis.
- To analyze risk factors and outcomes.
- To propose a revised therapeutic approach.
Main Methods:
- Case series analysis of 17 patients in the San Francisco Bay Area.
- Serotyping of Serratia isolates.
- Review of treatment strategies and patient outcomes.
Main Results:
- 15 of 17 patients were intravenous drug users.
- Right-sided endocarditis had a better prognosis than left-sided.
- Survival was poor for left-sided infections despite aggressive treatment.
Conclusions:
- Serratia marcescens endocarditis poses a significant challenge, especially in intravenous drug users.
- Treatment requires a tailored approach, considering valve location and patient factors.
- Further research into optimal therapeutic strategies is warranted.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

